CD16/CD32 mAb (2.4G2), InVivoPure+
AK3608P+
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
TargetFcgr2b
Product AK3608P+ is not available
Product not available
There may be an alternative product available, please contact our technical support team.
Overview
- SupplierInVivo Biotech
- Product NameCD16/CD32 mAb (2.4G2), InVivoPure+
- Delivery Days Customer5
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID2.4G2
- Concentration1 mg/ml
- ConjugateUnconjugated
- Estimated Purity>=95%
- FormulationLiquid
- Gene ID14130
- Target nameFcgr2b
- Target descriptionFc receptor, IgG, low affinity IIb
- Target synonymsAI528646; CD32; F630109E10Rik; fc gamma receptor IIB; Fc gamma RIIB; Fc[g]; Fc[g]RII; Fcg; Fcgamm; fc-gamma RII; Fc-gamma-RII; FcgammaRIIB; fc-gamma-RIIB; Fcgr; Fcgr2; Fcgr2a; FcgRII; Fcr-; Fcr-2; Fcr-3; fcRII; igG Fc receptor II beta; low affinity immunoglobulin gamma Fc region receptor II; low affinity immunoglobulin gamma Fc region receptor II-b; Ly-1; Ly-17; LyM-; LyM-1; Ly-m2; Ly-m20; lymphocyte antigen 17
- HostMouse
- IsotypeIgG2b
- Protein IDP08101
- Protein NameLow affinity immunoglobulin gamma Fc region receptor II
- Scientific DescriptionCD16/CD32 (2.4G2) rat antibody recognizes endogenous levels of total CD16/CD32 protein. This antibody detects an epitope within the extracellular domain and is expected to detect all isoforms of CD16 and CD32. 2.4G2 antibody blocks the interaction between IgG and CD16 or CD32, and therefore is used as a pre-treatment to minimize non-specific binding of antibodies to FcR-bearing cells. CD16/CD32 is expressed on NK cells, monocytes, macrophages, dendritic C (at low levels) kupper cells, granulocytes, mast cells, B lymphocytesand some activated T lymphocyte
- ReactivityMouse
- UNSPSC12352203